SLS

SELLAS Life Sciences

Exchangesession close: 12.30USD / shareMarket closedlast close 30 Sepsession change: +6.82%

Chainchain price: 12.36USD / Stock Tokencross check resultRobinhood book13 s

+52.9bps chain above exchange

Both markets are already on one share at this multiplier. 12.36 against 12.30.

Robinhood bookEvery route and its rule.

SLS

SELLAS Life SciencesUS81642T2096

SLS on the exchangesession close: 12.30session change: +6.82%Market closedlast close 30 Sep

+52.9bps apart

SLS on Robinhood Chainchain price: 12.36Robinhood bookRobinhood book13 s

Market cap2.49Bthe company's own, off the exchange close, never multiplied

Earnings per shareearnings per share, trailing twelve months: -0.22 USDper share, trailing twelve months, and per share always

Last reportedQ2 FY2026the company's own fiscal quarter, the latest it has reported

Next report10 Nov 2026the vendor's own calendar, confirmed

Valuation, growth and returns

Finnhub, read

Price to earningsPrice to earnings: Price to earnings: this vendor did not carry ittrailing twelve months, per share

Earnings per shareEarnings per share: -0.22 USDtrailing twelve months

Revenue per shareRevenue per share: 0.00 USDtrailing twelve months

Revenue growthRevenue growth: Revenue growth: this vendor did not carry ittrailing twelve months, year on year

Gross marginGross margin: 93.10%trailing twelve months

Operating marginOperating margin: -730.69%trailing twelve months

Net marginNet margin: -736.21%trailing twelve months

Return on equityReturn on equity: -35.91%trailing twelve months

Dividend per shareDividend per share: Dividend per share: this vendor did not carry ittrailing twelve months

Dividend yieldDividend yield: Dividend yield: this vendor did not carry itindicated annual

BetaBeta: 2.73against the vendor's own index

Current ratioCurrent ratio: 18.83most recent quarter

Debt to equityDebt to equity: 0most recent quarter

Payout ratioPayout ratio: Payout ratio: this vendor did not carry ittrailing twelve months

52 week high52 week high: 15.88 USDset 30 June 2026

52 week low52 week low: 1.39 USDset 2 December 2025

Every figure above is the company's and is per share. None of them is converted by the Stock Token multiplier, because a company's earnings do not change when a token accrues a dividend. The panel below is where the two units meet.

Finnhub, readthe company's figures, per share

Reported quarters

4 reportedFinnhub, read

Q2 FY2026
Reported
earnings per share reported: -0.05 USD
Estimate
earnings per share estimated: -0.05 USD
Surprise
surprise against the estimate: -9.89%, below the estimate
Q1 FY2026
Reported
earnings per share reported: -0.05 USD
Estimate
earnings per share estimated: -0.04 USD
Surprise
surprise against the estimate: -23.76%, below the estimate
Q4 FY2025
Reported
earnings per share reported: -0.05 USD
Estimate
earnings per share estimated: -0.07 USD
Surprise
surprise against the estimate: +23.90%, above the estimate
Q3 FY2025
Reported
earnings per share reported: -0.06 USD
Estimate
earnings per share estimated: -0.07 USD
Surprise
surprise against the estimate: +10.04%, above the estimate

QuarterReportedEstimateSurprise

Q2 FY2026earnings per share reported: -0.05 USDearnings per share estimated: -0.05 USDsurprise against the estimate: -9.89%, below the estimate

Q1 FY2026earnings per share reported: -0.05 USDearnings per share estimated: -0.04 USDsurprise against the estimate: -23.76%, below the estimate

Q4 FY2025earnings per share reported: -0.05 USDearnings per share estimated: -0.07 USDsurprise against the estimate: +23.90%, above the estimate

Q3 FY2025earnings per share reported: -0.06 USDearnings per share estimated: -0.07 USDsurprise against the estimate: +10.04%, above the estimate

Reported and estimated earnings are per share, as the company reports them. There is no per-token earnings figure and this tab does not derive one.

Finnhub, readeach quarter is the company's own fiscal quarter

Next report

confirmedFinnhub, read

Date: 10 November 2026time not stated
Quarter: Q3 FY2026
EPS estimate: estimated earnings per share: -0.05 USD
Revenue estimate: estimated revenue in dollars: not read

An estimate is the analyst consensus the vendor publishes, not a Corvus figure and not a prediction. It is printed because it is what the market is priced against.

The share and the token

the multiplierIssuer book, read13 s

Multiplier1xOne Stock Token is one share, so a figure below reads the same in either unit.

Chain price, per token12.36 USDThe cross check verdict, which is already in token space.

Chain price, per share12.36 USDThe same reading divided by the multiplier. This is the only figure on this tab that may be put beside one of the company's.

Price to earnings, on the chain priceno chain price, or the company did not earnThe company did not earn over the trailing twelve months, so there is no multiple to take.

Market cap the chain price implies2.43BThe vendor's own is 2.49B, off the exchange close.

43 of 195 Stock Tokens carry a multiplier other than 1.0, and the largest is 4x. On those names a multiple taken straight off the token price is off by that factor, which is why the division happens here and is written down.

Issuer book, readthe chain side, converted once13 s

The company

profileFinnhub, read

Name: Sellas Life Sciences Group Inc
Exchange: NASDAQ NMS - GLOBAL MARKET
Sector: Biotechnology
Country: US
Reports in: USD
Listed since: 12 March 2008
Market cap: 2.49Boff the exchange close
Shares outstanding: shares outstanding: 196,630,000
Free float: free float in shares: 194,770,000

The vendor states the last three in millions and says so nowhere in its payload. They are converted here, once, at the parser.

reading